𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: A population-based study in northern Sweden

✍ Scribed by Kristina Cederquist; Monica Emanuelsson; Ingela Göransson; Elke Holinski-Feder; Yvonne Müller-Koch; Irina Golovleva; Henrik Grönberg


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
105 KB
Volume
109
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder that predisposes to predominantly colorectal and endometrial cancers due to germline mutations in DNA mismatch repair genes, mainly MLH1, MSH2 and in families with excess endometrial cancer also MSH6. In this population‐based study, we analysed the mutation spectrum of the MLH1, MSH2 and MSH6 genes in a cohort of patients with microsatellite unstable double primary tumours of the colorectum and the endometrium by PCR, DHPLC and sequencing. Fourteen of the 23 patients (61%) had sequence variants in MLH1, MSH2 or MSH6 that likely affect the protein function. A majority (10/14) of the mutations was found among probands diagnosed before age 50. Five of the mutations (36%) were located in MLH1, 3 (21%) in MSH2 and 6 (43%) in MSH6. MSH6 seem to have larger impact in our population than in other populations, due to a founder effect since all of the MSH6 families originate from the same geographical area. MSH6 mutation carriers have later age of onset of both colorectal cancer (62 vs. 51 years) and endometrial cancer (58 vs. 48 years) and a larger proportion of endometrial cancer than MLH1 or MSH2 mutation carriers. We can conclude that patients with microsatellite unstable double primary cancers of the colorectum and the endometrium have a very high risk of carrying a mutation not only in MLH1 or MSH2 but also in MSH6, especially if they get their first cancer diagnosis before the age of 50. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Erratum to Cederquist et al., “Mutation
📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 27 KB 👁 1 views

## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (2004) 109(3) 370–376DOI: 10.1002/ijc.11718

Second primary cancers in patients with
✍ Cecilia Wassberg; Magnus Thörn; Jonathan Yuen; Ulrik Ringborg; Timo Hakulinen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 54 KB 👁 2 views

We studied second primary cancer among 25,947 patients diagnosed with squamous cell carcinoma of the skin (SCC) in Sweden between 1958 and 1992. In total, 5,706 patients developed a second primary cancer at any site, compared with an expected number of 2,651 [standardized incidence ratio (SIR) ‫؍‬ 2

Mutation analysis of the BRCA1 and BRCA2
✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi